Brachioplasty Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Procedure (Surgical, Non-Surgical), By End-Use (Hospitals, Cosmetic Surgery Clinics), By Region & Competition, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 1.26 Billion
CAGR (2026-2031)	6.71%
Fastest Growing Segment	Non-Surgical
Largest Market	North America
Market Size (2031)	USD 1.86 Billion

Market Overview

The Global Brachioplasty Market is projected to grow from USD 1.26 Billion in 2025 to USD 1.86 Billion by 2031 at a 6.71% CAGR. Brachioplasty, commonly known as an arm lift, is a surgical procedure designed to reshape the underside of the upper arm by excising excess skin and fat and tightening the underlying supportive tissue. This intervention is primarily sought by individuals experiencing skin laxity due to significant weight loss or the natural aging process. The global market for brachioplasty is significantly driven by a rising demand for aesthetic body contouring procedures, particularly from the increasing number of patients undergoing bariatric surgery who subsequently require skin excision. Further market expansion is supported by continuous advancements in surgical techniques.

According to the International Society of Aesthetic Plastic Surgery (ISAPS), 212,223 upper arm lift procedures were performed globally in 2024. Despite these growth factors, the market faces a notable challenge in the form of the procedure's relatively high cost, which can limit accessibility for a segment of potential patients.

Key Market Drivers

Obesity and post-bariatric procedures
The increasing incidence of obesity and the rising number of post-bariatric surgery procedures represent a significant driving factor for the Global Brachioplasty Market. Individuals who undergo substantial weight loss often contend with excess skin and fat, particularly in the upper arms, which cannot be addressed through diet and exercise alone. Bariatric surgery, while effective for weight management, frequently necessitates subsequent body contouring procedures to refine the new body shape and address skin laxity. According to new research presented at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS2026) on May 5, 2026, the number of metabolic and bariatric surgery procedures in the United States reached 177,297 cases in 2024, indicating a consistent patient pool requiring post-weight loss interventions such as brachioplasty.

Rising aesthetic awareness and contouring demand
Concurrently, the rising aesthetic consciousness and a pervasive desire for body contouring significantly influence market expansion. Modern societal emphasis on a toned physique, coupled with broader media exposure of cosmetic enhancements, contributes to increased awareness and acceptance of aesthetic procedures. As reported by Aesthetic Medicine Market Statistics on May 6, 2026, plastic surgeons performed 37.5 million aesthetic procedures globally in 2024, highlighting a widespread and growing interest in improving physical appearance. This general trend of seeking aesthetic improvements extends to procedures like arm lifts, appealing to individuals seeking to address age-related skin laxity or achieve a more sculpted arm contour. Furthermore, botulinum toxin remained the top non-surgical procedure with 7.8 million treatments in 2024, according to Aesthetic Medicine Market Statistics.

Download Free Sample Report

Key Market Challenges

The high cost associated with brachioplasty presents a significant impediment to the expansion of the global market. This financial barrier directly limits the accessibility of the procedure for a considerable portion of potential patients, thereby constraining the overall patient pool.

According to the American Society of Plastic Surgeons (ASPS), the average surgeon's fee for an arm lift in 2025 was approximately $6,192, a figure that typically excludes additional expenses such as anesthesia and operating room facilities. When these supplementary costs are included, the total investment for a patient can range from $6,000 to $12,000. Given that most health insurance plans do not cover elective cosmetic procedures like brachioplasty, the entire financial burden falls directly on the individual. This substantial out-of-pocket expenditure can deter many prospective patients, particularly those with budget constraints or insufficient disposable income, from pursuing the surgery, thus dampening market growth.

Key Market Trends

A significant shift in the global brachioplasty market is the burgeoning patient preference for minimally invasive and non-surgical arm contouring options. This trend reflects a broader consumer demand for aesthetic improvements with reduced downtime, fewer incisions, and faster recovery compared to traditional surgical interventions. These less invasive modalities, such as energy-based devices for skin tightening and localized fat reduction, are increasingly appealing to individuals seeking subtle refinements or those who are not candidates for extensive surgery. According to ALLWILL, May 2026, in "Why Non-Invasive Aesthetics Is Surging in 2026", the global non-invasive aesthetic treatment market is projected to grow from $76.7 billion in 2025 to $88.99 billion in 2026 at a 16.0% CAGR. This robust growth indicates a direct influence on the brachioplasty market, as patients explore alternatives that promise effective outcomes without the commitments of a full surgical arm lift.

Another pivotal trend impacting the Global Brachioplasty Market is the increasing integration of advanced digital technologies, including artificial intelligence, robotics, and 3D printing, into surgical planning and execution. These technologies promise enhanced precision, improved patient safety, and the ability to customize surgical outcomes with greater accuracy. Robotics, for instance, can assist surgeons with delicate tissue handling and complex dissections, potentially leading to more refined results and accelerated patient recovery. According to Sermo, May 2025, in "The Future of Robotics in Surgery: 2026 Trends & Advancements", analysts anticipate the market for robotic surgical devices to grow from $7.84 billion in 2024 to $8.89 billion in 2025, at a 13.4% compound annual growth rate. This technological evolution enables more sophisticated pre-operative planning and intra-operative guidance, influencing technique development and ultimately shaping patient expectations for surgical precision and results in brachioplasty.

Segmental Insights

The non-surgical segment is identified as the fastest-growing within the global brachioplasty market. This rapid expansion is primarily driven by increasing patient preference for minimally invasive and non-invasive procedures, which offer advantages such as reduced downtime, minimal scarring, and generally lower costs compared to traditional surgical interventions. Advancements in non-surgical skin-tightening technologies, including radiofrequency, ultrasound therapy, and laser treatments, have significantly enhanced the efficacy and appeal of these procedures. These innovations allow for effective treatment of early-stage skin laxity, further contributing to the segment's swift adoption and growth.

Regional Insights

North America stands as the dominant region in the global brachioplasty market, primarily due to several key factors. The region benefits from a robust healthcare infrastructure, high disposable income levels, and significant public acceptance of cosmetic surgeries. A high prevalence of obesity and a large number of bariatric surgeries performed annually in countries such as the United States directly translate into a greater need for subsequent body contouring procedures like brachioplasty. Additionally, the presence of numerous skilled plastic surgeons and well-established aesthetic clinics supports the high volume of procedures, contributing to North America's leading market position.

Recent Developments

• In December 2025, Cutera, Inc., a developer of laser and energy-based devices, announced it received FDA clearance for expanded rehabilitative and therapeutic indications for its truFlex muscle stimulation technology. The updated clearance includes strengthening, toning, and firming the muscles of the arms and calves, in addition to other rehabilitative applications such as relaxing muscle spasms and improving local blood circulation. While focusing on therapeutic benefits, the ability to tone and firm the arms positions truFlex as a complementary or alternative treatment for individuals seeking improved arm contour, thus holding relevance for the Global Brachioplasty Market by addressing muscular definition and firmness.
• In November 2025, Merz Aesthetics announced that its Ultherapy PRIME system received expanded clearance from the U.S. Food and Drug Administration (FDA) for new indications. This clearance allows the non-invasive ultrasound device to be used to improve the appearance of skin laxity on the anterior and posterior arms, as well as the abdomen. Ultherapy PRIME builds on the existing Ultherapy technology, providing real-time visualization to target collagen and elastin production for skin lifting and tightening. This advancement offers patients a non-surgical option for arm contouring, directly impacting the demand within the Global Brachioplasty Market by presenting an alternative to surgical procedures for addressing sagging arm skin.
• In November 2025, Cytrellis Biosystems, Inc. secured 510(k) clearance from the U.S. Food and Drug Administration for fractional skin resurfacing using its ellacor® Micro-Coring® technology. This significant development expands the application of ellacor beyond the face, enabling medical professionals to treat skin laxity on various body areas, including the arms. The technology removes micro-cores of skin without surgery or heat, stimulating natural collagen and elastin production for smoother, tighter skin. This product enhancement provides a minimally invasive solution for arm skin removal, directly influencing options available in the Global Brachioplasty Market for individuals seeking aesthetic improvement without traditional surgical incisions.
• In 2025, InMode Australia highlighted QuantumRF technology as a significant innovation in radiofrequency skin tightening. This advanced technology gained recognition as a sought-after alternative to traditional brachioplasties and thighplasties due to its ability to deliver effective skin tightening results without visible scarring. QuantumRF, part of the InMode IgniteRF multiplatform, utilizes advanced radiofrequency energy to stimulate collagen production in the deep layers of the skin. This minimally invasive approach for skin tightening offers a non-surgical option for arm contouring, directly impacting treatment choices within the Global Brachioplasty Market.

Key Market Players

• AbbVie Inc.
• Johnson & Johnson Services, Inc.
• Medtronic plc
• B. Braun Melsungen AG
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Integra LifeSciences Holdings Corporation
• CONMED Corporation
• Becton, Dickinson and Company

By Procedure	By End-Use	By Region
Surgical Non-Surgical	Hospitals Cosmetic Surgery Clinics	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Brachioplasty Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Brachioplasty Market, By Procedure:

• Surgical
• Non-Surgical

• Brachioplasty Market, By End-Use:

• Hospitals
• Cosmetic Surgery Clinics

• Brachioplasty Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE